
197
Acquisition strategies can be used to support use of both unrelated and related diversi-
fication strategies (see Chapter 6).
46
For example, United Technologies Corp. (UTC) uses
acquisitions as the foundation for implementing its unrelated diversification strategy.
Since the mid-1970s it has been building a portfolio of stable and noncyclical businesses
including Otis Elevator Co. (elevators, escalators, and moving walkways) and Carrier
Corporation (heating and air conditioning systems) in order to reduce its dependence on
the volatile aerospace industry. Pratt & Whitney (aircraft engines), Hamilton Sundstrand
(aerospace and industrial systems), Sikorsky (helicopters), UTC Fire & Security (fire
safety and security products and services), and UTC Power (fuel cells and power sys-
tems) are the other businesses in which UTC competes as a result of using its acquisition
strategy. While each business UTC acquires manufactures industrial and/or commercial
products, many have a relatively low focus on technology (e.g., elevators, air condition-
ers, and security systems).
47
In contrast to UTC, Procter & Gamble (P&G) uses acquisi-
tions to implement its related diversification strategy. Beauty, Health & Well-Being, and
Household Care are P&G’s core business segments. Gillette’s products are included in
the Beauty segment, where they are related to other products in this segment such as
cosmetics, hair care, and skin care. As noted earlier in the chapter, P&G completed a
horizontal acquisition of Gillette in 2006.
Firms using acquisition strategies should be aware that in general, the more related
the acquired firm is to the acquiring firm, the greater is the probability the acquisition
will be successful.
48
Thus, horizontal acquisitions and related acquisitions tend to con-
tribute more to the firm’s strategic competitiveness than do acquisitions of companies
operating in product markets that are quite different from those in which the acquiring
firm competes.
49
Reshaping the Firm’s Competitive Scope
As discussed in Chapter 2, the intensity of competitive rivalry is an industry characteris-
tic that affects the firm’s profitability.
50
To reduce the negative effect of an intense rivalry
on their financial performance, firms may use acquisitions to lessen their dependence on
one or more products or markets. Reducing a company’s dependence on specific markets
shapes the firm’s competitive scope.
Each time UTC enters a new business (such as UTC Power, the firm’s latest busi-
ness segment), the corporation reshapes its competitive scope. In a more subtle manner,
P&G’s acquisition of Gillette reshaped its competitive scope by giving P&G a stron-
ger presence in some products for whom men are the target market. By merging their
operations, Towers Perrin and Watson Wyatt reshaped the scope of their formerly inde-
pendent firms’ operations in that Towers was stronger in health care consulting while
Watson Wyatt was stronger in pension consulting. Thus, using an acquisition strategy
reshaped the competitive scope of each of these firms.
Learning and Developing New Capabilities
Firms sometimes complete acquisitions to gain access to capabilities they lack. For exam-
ple, acquisitions may be used to acquire a special technological capability. Research shows
that firms can broaden their knowledge base and reduce inertia through acquisitions.
51
though, Pfizer seeks to rely on Wyeth’s capabilities in the biotechnology space to develop
new products that the newly formed firm can quickly introduce to the market.
Sources: 2009, Pfizer’s acquisition of Wyeth brings scale but will fail to deliver sustainable sales growth, Trading Markets.
com, http://www.tradingmarkets.com, January 28; C. Arnst, 2009, The drug mergers’ harsh side effects, BusinessWeek
Online, http://www.businessweek.com, March 12; R. Jana, 2009, Do ideas cost too much? BusinessWeek, April 20,
46–58; J. Jannarone, 2009, Pfizer treatment is no cure, Wall Street Journal Online, http://www.wsj.com, January 24; S.
Pettyprice, T. Randall, & Z. Mider, 2009, Pfizer’s $68 billion Wyeth deal eases Lipitor loss, Bloomberg.com, http://www
.bloomberg.com, January 26.